Abdullah Esmail
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Hepatology 25
- Hepatocellular Carcinoma Treatment and Prognosis 25
- Oncology 17
- Pancreatic and Hepatic Oncology Research 9
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Maen Abdelrahim (42 shared papers)Rafik Mark Ghobrial (15 shared papers)Ala Abudayyeh (12 shared papers)Ashish Saharia (12 shared papers)David W. Victor (7 shared papers)Sudha Kodali (9 shared papers)Robert R. McMillan (4 shared papers)Naoka Murakami (4 shared papers)
- Journals
- Cancers (14 papers)Frontiers in Oncology (4 papers)Frontiers in Pharmacology (3 papers)Journal of Clinical Medicine (2 papers)HPB (2 papers)
- Partner nations
- United StatesJordanSaudi Arabia
In The Last Decade
Abdullah Esmail
42 papers receiving 573 citations
Peers
Comparison fields: 5 of 40
- Hepatology 236
- Oncology 160
- Cancer Research 52
- Surgery 154
- Transplantation 6
Countries citing papers authored by Abdullah Esmail
This map shows the geographic impact of Abdullah Esmail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Esmail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Esmail more than expected).
Fields of papers citing papers by Abdullah Esmail
This network shows the impact of papers produced by Abdullah Esmail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Esmail. The network helps show where Abdullah Esmail may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdullah Esmail, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 66 | |
| 2 | 2021 | 48 | |
| 3 | 2022 | 43 | |
| 4 | 2022 | 39 | |
| 5 | 2022 | 31 | |
| 6 | 2024 | 31 | |
| 7 | 2024 | 28 | |
| 8 | 2022 | 24 | |
| 9 | 2022 | 20 | |
| 10 | 2022 | 20 | |
| 11 | 2022 | 19 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 16 | |
| 14 | 2022 | 16 | |
| 15 | 2023 | 15 | |
| 16 | 2024 | 13 | |
| 17 | 2022 | 12 | |
| 18 | 2023 | 12 | |
| 19 | 2024 | 11 | |
| 20 | 2025 | 11 |
About Abdullah Esmail
Abdullah Esmail is a scholar working on Hepatology, Oncology, Cancer Research, Surgery and Complementary and alternative medicine, having authored 55 papers that have together received 575 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Cancer Genomics and Diagnostics (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Organ Transplantation Techniques and Outcomes (2 papers), Nigella sativa pharmacological applications (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Hepatology (236 citations), Oncology (160 citations), Cancer Research (52 citations), Surgery (154 citations) and Transplantation (6 citations). Abdullah Esmail has collaborated with scholars based in United States, Jordan and Saudi Arabia. Frequent co-authors include Maen Abdelrahim, Rafik Mark Ghobrial, Ala Abudayyeh, Ashish Saharia, David W. Victor, Sudha Kodali, Robert R. McMillan, Naoka Murakami, Ahmed Osama Gaber and Jenny C. Chang. Their work appears in journals such as Cancers, Frontiers in Oncology, Frontiers in Pharmacology, Journal of Clinical Medicine and HPB.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.